1:1 bonus issue and INR 7 interim dividend approved
LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.2 pts more than Nifty Smallcap 250 and 1.6 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The board approved a 1:1 bonus issue, giving each shareholder one extra fully paid share with face value INR 10 for each share held, subject to shareholder and regulatory approvals. About 83.78 million bonus shares are proposed. It also declared a second interim dividend of INR 7 per share; November 7, 2025 is the record date, with payment within 30 days. The bonus record date will be announced later. Unaudited results for the quarter and half year ended September 30, 2025 were also approved.
Shareholders gain extra shares and INR 7 per share in cash, which may support sentiment. The bonus does not create value by itself and still needs approvals.